Emerging epidemiological evidence indicates that low serum high-density lipoprotein
cholesterol (HDL-C) levels are associated with the risk of progression of chronic kidney …

Background High‐density lipoprotein cholesterol (HDL‐C) levels are generally decreased in
patients with chronic kidney disease (CKD). However, studies on the relationship between …

Objectives Patients with chronic kidney disease (CKD) often present with reduced plasma
HDL cholesterol (HDL‐C) levels. Whether this reduction in an epiphenomenon or is involved …

Available experimental evidence suggests a role for high-density lipoprotein cholesterol
(HDL-C) in incident chronic kidney disease (CKD) and its progression. However, clinical …

In the general population, HDL cholesterol (HDL-C) is associated with reduced
cardiovascular events. However, recent experimental data suggest that the vascular effects …

Highlights•A total of 3% participants developed new-onset CKD during 2.8 years follow-
up.•NonHDLc/HDLc is associated with a greater risk of the new-onset CKD.•The risk of CKD …

Background Recent data suggest a U-shaped association between high-density lipoprotein
cholesterol (HDL-c) and death in chronic kidney disease (CKD). However, whether the …

Objective: Chronic kidney disease (CKD) and cardiovascular disease (CVD) have a high
morbidity and mortality among the elderly. Low levels of high-density lipoprotein cholesterol …

Background High-density lipoprotein (HDL) confers protection against atherosclerosis by
several different mechanisms. Although in the general population, increasing levels of HDL …

Background Increased total cholesterol (TC), triglycerides (TG), low-density lipoprotein
cholesterol (LDL-C), and decreased high-density lipoprotein cholesterol (HDL-C) …